Hello, welcome to the 2026 Annual Meeting of Stockholders for Praxis Precision Medicines. It is my pleasure to turn today's meeting over to Dean Mitchell. Mr. Mitchell, the floor is yours.
Good morning. I'm Dean Mitchell, Chairman of Board of Directors of Praxis Precision Medicines, Inc., and the Chairman of today's meeting. On behalf of the company, I'm pleased to welcome you to our annual meeting. Before I call the meeting to order, I'd like to introduce you to the members of our Board of Directors and the other officers of the company who are joining us virtually today. The members of the Board present today are myself, Stuart Arbuckle, Jeff Chodakewitz, Merit Cudkowicz, Jill Desimone, Jeffrey Kindler, Greg Norden, William Young, and Marcio Souza, Director and the company's Chief Executive Officer. The officers joining from the company are Tim Kelly, Chief Financial Officer, Megan Sniecinski, Chief Operating Officer, Alex Nemiroff, General Counsel, and Lauren Mastrocola, Senior Vice President, Finance, and Principal Accounting Officer.
Our independent auditors, the firm of Ernst & Young LLP, is represented at this meeting by Brendan McCrory. The meeting will now officially come to order. We'll proceed with the formal business of the meeting as set forth in the notice of annual meeting and proxy statement. In the virtual meeting portal, you'll find the meeting agenda as well as the rules of conduct of the meeting. To conduct an orderly meeting, we ask the participants abide by these rules. Note that only stockholders who are logged into the meeting using their 16-digit control number will be able to vote and submit questions. If you'd like to submit a question relating to the proposals, you may enter your question in the question and answer function in the virtual meeting portal. You must include your name, and if applicable, organization with your question.
The Corporate Secretary will file the proof of mailing of notice of the meeting with the record of the meeting. All stockholders of record at the close of business on April the 15th, 2026, or holders of a valid proxy, are entitled to vote at the meeting. A complete list of the holders of record of the outstanding shares of the company's common stock on the record date for the meeting has been available for inspection at the company's headquarters for the last 10 days. At this time, I'd like to introduce Cheryl Niebeling, who the Board of Directors has appointed to act as Inspector of Election at today's meeting. Ms. Niebeling has signed the customary oath of office to execute her duties with strict impartiality. We'll file this oath with the records of the meeting. Ms. Niebeling, do we have a quorum present?
Mr. Chairman, of the 27,872,305 shares of common stock entitled to vote, 26,724,231 shares are represented, either in person or by proxy, and therefore, a quorum is present.
I declare that a quorum is present. We may now proceed to transact the business for which this meeting has been called. The time is now 9:04 A.M. on June the 10th, 2026. The polls are open for voting on all matters before the meeting. If you wish to vote and you haven't already, please vote now by clicking on the Voting button in the virtual meeting portal. You do not need to vote electronically if you've already sent in your signed proxy or if you voted by telephone or internet in advance of the meeting. There are three proposals to be considered by the stockholders at this meeting. The company recommends that the stockholders vote for each of these proposals.
The first item of business is the election of Greg Norden, Marcio Souza, and William Young as Class III members of the company's board of directors to serve until the 2029 annual meeting of stockholders. The company's bylaws require that a stockholder provide advance notice to the company of a stockholder's intent to nominate persons as directors. No such notice was received. Accordingly, I declare the nominations for directors closed. Are there any questions concerning the proposal? The second item of business is the ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December the 31st, 2026. The audit committee of the board appointed Ernst & Young as the company's independent registered public accounting firm to audit the company's financial statements for the fiscal year ending December the 31st, 2026.
The board approved the selection of Ernst & Young and has asked the stockholders to ratify the selection. Are there any questions concerning the proposal? The third item of business is the approval on an advisory basis of the compensation of the company's named executive officers as set forth in the proxy statement. The vote on this item is advisory. It will be non-binding on our Compensation Committee. However, our board and our Compensation Committee value the opinions of our stockholders. Our Compensation Committee will consider the outcome of this vote when evaluating our executive compensation policies and practices and making future compensation decisions. Are there any questions concerning the proposal? That was the final proposal for today's meeting. We will pause briefly to allow stockholders to submit any final votes.
The time is now 9:07 A.M. on June 10th, 2026. The polls are now closed for voting. Ms. Niebeling, please report on the results of the voting.
With regard to proposal one, the affirmative vote of a plurality of the votes cast at the annual meeting has been voted in favor of each director candidate. With regard to proposal two, the affirmative vote of the holders of a majority of the votes cast at the annual meeting has been voted in favor. With regard to proposal three, the affirmative vote of the holders of a majority of the votes cast at the annual meeting has been voted in favor.
Thank you. I declare that all of the proposals presented at the meeting have been approved by the stockholders. The final tally of the votes will be published within four business days in a current report on Form 8-K to be filed with the Securities and Exchange Commission. There being no other matters for consideration at this meeting, I hereby adjourn the meeting. Thank you all for attending, and thank you for your continued support.
This concludes the meeting. You may now disconnect.